Modalis Therapeutics Corporation

Modalis Therapeutics Corporationverified

4883.T

Price:

$63

Market Cap:

$4.85B

Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies for genetic diseases using its proprietary CRISPR-GNDM technology that enables to control gene expressions through modulating the switch (epigenetics of a specific locus. The company has a. joint research agreement with JCR Pharmaceuticals Co., Ltd. to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corp...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-08-03

Stock Exchange

JPX

Ticker

4883.T

The Enterprise Value as of December 2025 (TTM) for Modalis Therapeutics Corporation (4883.T) is 1.59B

According to Modalis Therapeutics Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 1.59B. This represents a change of -22.87% compared to the average of 2.06B of the last 4 quarters.

Modalis Therapeutics Corporation (4883.T) Historical Enterprise Value (quarterly & annually)

How has 4883.T Enterprise Value performed in the past?

The mean historical Enterprise Value of Modalis Therapeutics Corporation over the last ten years is 21.80B. The current 1.59B Enterprise Value has changed 627.28% with respect to the historical average. Over the past ten years (40 quarters), 4883.T's Enterprise Value was at its highest in in the September 2022 quarter at 7.47B. The Enterprise Value was at its lowest in in the December 2024 quarter at 1.12B.

Quarterly (TTM)
Annual

Average

21.80B

Median

9.75B

Minimum

1.13B

Maximum

54.90B

Modalis Therapeutics Corporation (4883.T) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Modalis Therapeutics Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Enterprise Value = 54.90B

Minimum Annual Increase = -76.00%

Minimum Annual Enterprise Value = 1.13B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20241.13B-52.31%
20232.37B-65.25%
20226.82B-46.27%
202112.69B-76.00%
202052.86B-3.71%

Modalis Therapeutics Corporation (4883.T) Average Enterprise Value

How has 4883.T Enterprise Value performed in the past?

The current Enterprise Value of Modalis Therapeutics Corporation (4883.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.44B

5-year avg

15.17B

10-year avg

21.80B

Modalis Therapeutics Corporation (4883.T) Enterprise Value vs. Peers

How is 4883.T’s Enterprise Value compared to its peers?

Modalis Therapeutics Corporation’s Enterprise Value is less than SymBio Pharmaceuticals Limited (3.12B), less than Nippon Chemiphar Co., Ltd. (14.84B), less than Cyfuse Biomedical K.K. (4.22B), less than WDB coco Co., Ltd. (2.90B), less than PRISM BioLab Co.,LTD (3.21B), less than MedRx Co., Ltd (4.86B), less than Solasia Pharma K.K. (7.06B), less than Shigematsu Works Co., Ltd. (9.00B), less than Pharmarise Holdings Corporation (15.39B), less than D. Western Therapeutics Institute, Inc. (4.03B),

Build a custom stock screener for Modalis Therapeutics Corporation (4883.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Modalis Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Modalis Therapeutics Corporation (4883.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Modalis Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Modalis Therapeutics Corporation's Enterprise Value?

What is the highest Enterprise Value for Modalis Therapeutics Corporation (4883.T)?

What is the 3-year average Enterprise Value for Modalis Therapeutics Corporation (4883.T)?

What is the 5-year average Enterprise Value for Modalis Therapeutics Corporation (4883.T)?

How does the current Enterprise Value for Modalis Therapeutics Corporation (4883.T) compare to its historical average?